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Abstract: The effect of dietary macronutrient composition on adipokine concentrations 
remains unclear. Greater reductions in leptin have been reported in participants who followed 
low-carbohydrate versus low-fat diets, although these studies did not adjust for the important 
effects of weight loss on adipokines. We investigated the effect of macronutrient composi-
tion on adipokine levels in 144 obese, diabetic participants who were randomly assigned to 
a   low-carbohydrate (,30 g/day) or low-fat diet (#30% of calories from fat with a deficit of 
500 kcal/day). Weight, adipokines, and dietary intake were assessed at baseline and 6 months. 
Complete data were available for 79 participants. At month 6, weight, leptin, adiponectin, and 
tumor necrosis factor-α concentrations did not differ significantly between groups (P . 0.05 
for all variables). However, significant changes in leptin and adiponectin occurred over time 
(P , 0.001 and P , 0.012, respectively). Modest weight loss, rather than macronutrient 
  composition, likely accounted for the favorable changes observed in leptin and adiponectin 
over time.
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Introduction
Adipocyte-derived hormones, known as adipokines, are important determinants 
of insulin resistance.1 Key adipokines include the insulin-sensitizing hormone, 
  adiponectin, and the proinflammatory hormones, tumor necrosis factor (TNF)-α 
and leptin. Leptin also plays a role in glucose homeostasis by enhancing the ability 
of insulin to inhibit hepatic glucose production.2 In contrast, TNF-α is believed to 
impair insulin secretion and has been found to induce β-cell apoptosis in pancre-
atic islets isolated from experimental animals and humans.3 Weight loss is known 
to induce favorable changes in adipokine levels in both nondiabetic and diabetic 
participants,4–6 but the relationship between macronutrient intake and adipokines is 
less clear.7–11 Although several studies suggest that weight loss, rather than macronutri-
ent composition, mediates improvements in TNF-α and adiponectin,7–9 the effect of 
dietary intake on leptin has been more variable.10,11 Greater reductions in leptin have 
been reported in persons who followed a low-carbohydrate diet than a low-fat diet, 
although these studies did not adjust for weight loss. Additionally, previous studies 
have included mainly nondiabetic individuals; investigators do not know whether the 
presence of diabetes modifies the effect of macronutrient composition on adipokine 
  concentrations. Thus, we sought to determine the effect of a low-carbohydrate versus 
a low-fat diet on adiponectin, leptin, and TNF-α levels, independent of weight loss, 
in obese   individuals with diabetes.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3
Table 1 Baseline characteristics of participants randomly assigned 
to either a low-carbohydrate or low-fat diet
Variable Low carbohydrate 
(n = 37)
Low fat 
(n = 42)
Age, years (SD) 60.8 (10.3) 58.6 (9.2)
BMi, kg/m2 (SD) 38.2 (6.0) 36.1 (4.6)
Male gender, number (%) 30 (81.8) 40 (95.2)
race, number (%)
White 14 (37.8) 18 (42.9)
Black 23 (62.0) 22 (52.4)
Other 0 2 (4.8)
Medications for diabetes,  
number (%)
insulin 7 (20.0) 11 (32.4)
Metformin 25 (71.4) 18 (52.9)
Thiazolidinedione 5 (14.3) 6 (17.7)
Sulfonylurea 23 (65.7) 19 (55.9)
hypertension, number (%) 27 (73.0) 33 (78.6)
hyperlipidemia, number (%) 21 (56.8) 32 (76.2)
coronary artery disease,  
number (%)
10 (27.0) 13 (31.0)
cigarette smoking, number (%) 4 (10.8) 8 (19.1)
Notes: Values are expressed as means (SD), unless otherwise specified. There 
were no significant baseline differences between groups.
Abbreviations: SD, standard deviation; BMi, body mass index.
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Research design and methods
The present investigation is an exploratory ancillary study 
to a randomized controlled trial that has been reported in 
detail previously.12 Briefly, 144 obese, diabetic participants 
were recruited from outpatient clinics at the Philadelphia 
Veterans Affairs Medical Center, Philadelphia, PA, USA. 
Inclusion criteria included individuals with type 2 diabetes, 
aged 18 years and above, and a body mass index $ 30 kg/m2. 
Exclusion criteria included an HbA1c . 12.0%, weight loss 
$ 5% in the past 3 months, active participation in a weight 
loss program, and the use of weight-loss medications. Men 
were randomized in a 1:1 ratio, and women were randomized 
separately in blocks of four to ensure equal representation 
in the two dietary conditions. Seventy participants were 
randomly assigned to a low-carbohydrate diet (,30 g/day 
without limitations on fat or caloric intake) and 74 to a low-
fat diet (#30% calories from fat and a deficit of 500 kcal/
day). For the first month, participants in each group attended 
separate weekly group sessions (led by a registered dietitian), 
followed by monthly sessions thereafter. All participants 
received treatment-specific diet handouts, sample menus 
and recipes, and a book about counting calories and carbo-
hydrates. The Institutional Review Board of the Philadelphia 
Veterans Affairs Medical Center approved this study. All 
participants provided written informed consent.
Outcome measures
Outcome measures were obtained at baseline and month 6. 
Weight was measured on a single calibrated scale (SR Instru-
ments, Inc., Tonawanda, NY) at each visit (with participants 
in light clothing without shoes). Serum total   leptin and 
adiponectin concentrations were measured in duplicate by 
double antibody radioimmunoassay (Millipore, St Charles, 
MO). Serum TNF-α was measured by a high sensitivity 
ELISA (R&D Systems, Minneapolis, MN). Twenty-four 
hour dietary recall was collected at baseline and month 6. All 
dietary data were analyzed using the Nutribase Management 
software (Cybersoft, Houston, TX).
Statistical analyses
Only participants with baseline and month 6 measurements 
for leptin, adiponectin, and TNF-α were included in the 
analysis, as the goal was to evaluate the effect of diet on 
adipokine concentrations. Baseline characteristics were 
described using means (standard deviations) for continuous 
data and percentages for categorical variables. Values for 
leptin, adiponectin, and TNF-α were log transformed prior 
to analysis to normalize the distribution of the data. Repeated 
measures ANOVAs (time × diet group) were performed to 
compare changes in weight, adipokines, and dietary intake 
from baseline to month 6. Correlations were used to examine 
associations between weight loss and change in adipokine 
concentrations. Separate multivariable linear regression 
models were fit for adiponectin, leptin, and TNF-α. The 
dependent variable for each dietary assignment was change 
in the respective antipokines, and change in weight was 
included as an explanatory variable. An alpha level of 0.05 
was considered statistically significant. Analyses were per-
formed with SPSS 17.0 (SPSS Inc, Chicago, IL).
Results
Seventy-nine participants (37 in the low-carbohydrate and 
42 in the low-fat group) had complete adipokine data at 
month 6 and were included in the final analysis. A higher 
attrition rate was seen in the low-carbohydrate condition than 
in the low-fat condition (47.1% versus 43.2%, respectively), 
but it was not statistically significant (P = 0.728). Most 
participants who dropped out cited disinterest in the study, 
difficulty in attending sessions at the Philadelphia Veterans 
Affairs Medical Center, or frustration with lack of weight 
loss. Twenty-eight participants did not provide reasons for 
discontinuing the study.
There were no significant differences between groups at 
baseline (Table 1). Participants with complete adipokine data 
did not differ significantly from those who dropped out with Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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respect to demographic variables, weight and anthropometric 
measurements, classes of diabetic medications, indices of 
glycemic control, or diet composition (data not shown).
change in weight and glycemic 
parameters
At month 6, participants in the low-carbohydrate group lost 
a mean (SD) of 4.0 (6.3) kg compared to 2.2 (5.3) kg in the 
low-fat group (−3.5% versus −1.9% of initial body weight, 
respectively). Weight declined significantly in all partici-
pants (P , 0.001) over time, but there were no significant 
differences between groups (P = 0.181). At month 6, waist 
circumference did not differ significantly between groups 
(P = 0.700). HbA1c decreased by 0.6% in the low-carbo-
hydrate group and by 0.1% in the low-fat group at month 6, 
although the difference did not reach statistical significance. 
Changes in weight, waist circumference, glycemic param-
eters, and adipokine concentrations are shown in Table 2.
changes in leptin, adiponectin, and TnF-α
Leptin decreased in both dietary conditions at month 6 
(Table 2), but changes between groups were not signifi-
cant (P = 0.320). Leptin decreased significantly by 18% 
(−4.4 [12.7] ng/mL; P , 0.001) from baseline to month 6 
across groups. Adiponectin increased in both conditions 
by month 6, but again there were no significant differ-
ences between groups (P = 0.777). However, a significant 
increase in adiponectin (25%) was observed over time 
(+3.5 [12.1] ng/mL; P , 0.012). Similar to leptin and adi-
ponectin, TNF-α concentrations did not differ significantly 
between groups. Although TNF-α decreased modestly in both 
groups from baseline to month 6, the change did not differ 
significantly with time (P = 0.340) or by dietary   assignment 
(P = 0.475).
Weight loss at month 6 was significantly associated with 
changes in leptin (r = 0.36; P = 0.001) and TNF-α (r = −0.29; 
P = 0.014), but not adiponectin (r = −0.07; P = 0.539). Thus, 
individuals who lost more weight had greater reductions in 
leptin and TNF-α. In multivariable linear regression analysis, 
dietary assignment was not associated with change in any 
of the adipokine concentrations after controlling for weight 
loss (Table 3). However, there was a trend toward a greater 
decrease in leptin in the low-fat group, after controlling for 
weight loss (P = 0.090).
changes in dietary intake
Caloric intake did not differ significantly between groups 
(P = 0.319), but decreased significantly over time by 263.2 
(1022.4) kcal/day (P = 0.035). The distribution of macronu-
trient intake did not differ significantly between groups at 
month 6 (Table 4).
Discussion
This investigation examined the effect of macronutrient 
composition on adipokine concentrations, independent of 
weight loss, in obese individuals with diabetes. Changes 
in adiponectin, leptin, and TNF-α concentrations did not 
differ significantly between dietary groups at 6 months. 
Table 2 Between group comparisons of the change in weight, 
adipokines, and metabolic data from baseline to month 6
Variable Low carbohydrate 
(n = 37)
Low fat 
(n = 42)
Weight, kg
Baseline 118.7 (24.4) 115.4 (22.3)
Δ from baseline to month 6 −4.0 (6.3) −2.2 (5.3)
Waist circumference, cm
Baseline 121.0 (21.4) 121.9 (10.4)
Δ from baseline to month 6 −2.4 (21.7) 2.4 (4.4)
Adiponectin, μg/mL
Baseline 13.4 (9.1) 16.0 (9.9)
Δ from baseline to month 6 2.6 (8.4) 4.3 (14.6)
Leptin, ng/mL
Baseline 25.2 (14.7) 22.2 (18.3)
Δ from baseline to month 6 −3.0 (11.9) −5.6 (13.3)
TnF-α, pg/mL
Baseline 3.4 (7.1) 1.9 (1.1)
Δ from baseline to month 6 −1.5 (7.1) −1.5 (5.6)
insulin, μU/mL
Baseline 22.9 (12.9) 26.8 (18.1)
Δ from baseline to month 6 −3.7 (12.1) 1.9 (25.2)
hbAlc, %
Baseline 8.1 (1.8) 7.3 (1.5)
Δ from baseline to month 6 −0.6 (1.2) −0.1 (1.2)
Notes:  Values  are  expressed  as  mean  (standard  deviation),  unless  otherwise 
specified. Weight, adipokines, and metabolic data did not differ significantly between 
groups at any point.
Table 3 results from the multiple linear regression model to 
examine the association between dietary assignment and change 
in adipokines, while controlling for weight change from baseline 
to month 6
Variable Coefficient 95% confidence 
interval
P value
Adiponectin
Diet assignment −0.056 −0.113, 0.069 0.636
Weight change 0.016 −0.11, 0.12 0.927
Leptin
Diet assignment 0.183 −0.012, 0.165 0.090
Weight change 0.573 0.009, 0.032 0.001
TnF-α
Diet assignment −0.038 −2.07, 0.149 0.749
Weight change 0.313 −0.005, 0.48 0.110Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
360
Vetter et al
However, despite very modest weight loss, significant and 
favorable changes in adiponectin and leptin occurred over 
time. This finding is consistent with three recent reports 
of significant increases in adiponectin with as little as 5% 
weight loss.13–15
Leptin decreased significantly over time and was 
significantly associated with weight loss. Miller and col-
leagues reported similar reductions in leptin in women 
who achieved equivalent weight loss on either a low-
carbohydrate or low-fat diet, suggesting that weight loss, 
rather than macronutrient composition, accounts for the 
change.7 Two recent studies reported significantly lower 
leptin concentrations in participants who followed a low-
carbohydrate diet, but failed to adjust for weight loss.9,10 
Findings from the present study further support the notion 
that favorable changes in leptin are mediated primarily by 
weight loss.
Although several studies have reported significant 
changes in adipokines with very modest weight loss similar 
to that achieved in the present study, the presence of dia-
betes may have attenuated changes in response to weight 
loss. In a small study that compared changes in adipokine 
concentrations between diabetic and nondiabetic partici-
pants who achieved substantial and equivalent weight loss 
following gastric bypass, Whitson and colleagues reported 
significant changes in adiponectin and TNF-α levels only in 
the nondiabetic participants.16 Leptin decreased significantly 
within both groups. The authors speculated that physiologic 
responses to weight loss differ between individuals with and 
without diabetes, and this may account for the favorable 
changes in adipokine concentrations observed in the nondia-
betic participants. Further studies are needed to corroborate 
this finding and explore the potential mechanisms by which 
diabetes may attenuate favorable changes in adipokine levels 
in response to weight loss.
The present study had several limitations. Because 
both groups failed to fully achieve their dietary targets at 
month 6, we cannot draw firm conclusions about the effect 
of macronutrient composition on adipokine levels. However, 
caloric intake was similar between groups at month 6, sug-
gesting that caloric restriction and weight change were the 
principal determinants of changes in adipokines, rather than 
macronutrient intake. Based on the reported caloric deficit 
and the actual weight change at month 6, it appears that 
participants in both groups (particularly those in the low-fat 
group) substantially underestimated their intake. Because 
a 24-h food recall has modest reliability and validity,17 a 
3-day food record may have better captured typical dietary 
intake. Many participants did not return for follow-up at 
month 6. However, comparable attrition rates of 40%–50% 
have been reported in several studies that compared low-
carbohydrate and low-fat diets, with lack of interest in the 
diet or failure to lose weight commonly cited as reasons for 
study discontinuation.18–21 As the purpose of the study was to 
evaluate the effect of dietary intake on adipokine concentra-
tions, only participants who had data at baseline and month 
6 were included in the analysis. Power to detect differences 
between groups was reduced because of the small sample 
size. In addition, we were unable to assess the independent 
effect of diabetes because nondiabetic individuals were 
excluded from the study.
This study highlights the beneficial effects of very modest 
weight loss on adiponectin and leptin, regardless of dietary 
macronutrient composition. As the weight loss achieved in 
both groups did not differ significantly from one another, 
the present study reinforces the concept that any type of 
diet can effectively reduce weight and improve metabolic 
parameters.22 Diets that can be tailored to individual patients 
according to their personal preferences may have the greatest 
likelihood of achieving long-term success with weight loss 
and maintenance.
In summary, weight, adipokine levels, and dietary 
intake did not differ significantly between dietary groups 
at 6 months. Modest weight loss, rather than macronutrient 
composition, likely accounted for the favorable changes 
observed in leptin and adiponectin over time. The relation-
ship between macronutrient composition and change in 
adipokine levels should be evaluated separately in diabetic 
and nondiabetic populations to investigate the potential for 
effect modification by diabetes status.
Table 4 Between group comparisons of the change in dietary 
intake from baseline to month 6
Variable Low carbohydrate 
(n = 37)
Low fat 
(n = 42)
caloric intake, kcal
Baseline 2056.0 (762.2) 1967 (708.1)
Δ from baseline to month 6 −138.9 (1216.8) −380.7 (796.3)
carbohydrate, g
Baseline 202.4 (112.2) 211.2 (84.8)
Δ from baseline to month 6 −46.7 (127.6) −37.1 (123.4)
Protein, g
Baseline 94.0 (50.5) 88.2 (36.7)
Δ from baseline to month 6 −8.1 (61.4) −2.8 (45.7)
Fat, g
Baseline 98.7 (45.3) 87.9 (51.1)
Δ from baseline to month 6 −5.9 (63.9) −23.3 (48.8)
Notes:  Values  are  expressed  as  mean  (standard  deviation),  unless  otherwise 
specified. Dietary intake did not differ significantly between groups at any point.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
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